Establishing genomic epidemiology hubs across Latin America
- Funded by Wellcome Trust
- Total publications:0 publications
Grant number: 223610/B/21/Z
Grant search
Key facts
Disease
COVID-19Start & end year
20212024Known Financial Commitments (USD)
$3,782,747.27Funder
Wellcome TrustPrincipal Investigator
Dr. Andrea VicariResearch Location
SwitzerlandLead Research Institution
World Health Organization, SwitzerlandResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Pathogen genomics, mutations and adaptations
Special Interest Tags
N/A
Study Type
Not applicable
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
In 2020 The Pan American Health Organization (PAHO) established and now coordinates the COVID-19 Genomic Surveillance Regional Network. It includes 21 collaborating countries of which 10 do not have any appropriate in-country sequencing capacity and instead send their samples externally for sequencing to the network reference laboratories in Brazil and Chile. Here we propose to build direct sequencing and analytical capacity in all participating laboratories to generate relevant genomic data that can be used for public health decision making. Where batch sequencing capacity already exists we propose to use MinIon platforms to extend the within-country capacity to investigate changing patterns of disease. Combined, this will dramatically increase our understanding of the known and new SARS-CoV-2 variants circulating in this region. We will develop a hub-and-spoke organization with PAHO at the center forming the hub for coordination, training and data flow and the Network laboratories forming the spokes. Laboratories with existing genomics expertise will help build genomics surveillance capacity in those that don't. Combining local and international expertise we aim to develop a regional network able to produce actionable SARS-CoV-2 data now with the potential to become a sustainable network able to track other diseases of regional importance in the future.